References
- US Food and Drug Administration. Fluzone quadrivalent; 2016 [accessed 2017 Feb 15]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm356091.htm.
- Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. Vaccine. 2013;31:770-6. https://doi.org/10.1016/j.vaccine.2012.11.074. PMID:23228813
- Greenberg DP, Robertson CA, Landolfi VA, Bhaumik A, Senders SD, Decker MD. Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatr Infect Dis J. 2014;33:630-6. https://doi.org/10.1097/INF.0000000000000254. PMID:24445833
- Committee for Medicinal Products for Human Use. Note for guidance on harmonisation of requirements for influenza vaccines; 1997 [accessed 2017 Feb 15]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
- Committee for Medicinal Products for Human Use. Guideline on influenza vaccines. Non-clinical and clinical module; 2016 [accessed 2017 Feb 15]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211324.pdf.
- Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, Tsai T, Clemens R, Rappuoli R. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011;30:1081-5. https://doi.org/10.1097/INF.0b013e3182367662. PMID:21983214
- Gravenstein S, Drinka P, Duthie EH, Miller BA, Brown CS, Hensley M, Circo R, Langer E, Ershler WB. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc. 1994;42:245-51. https://doi.org/10.1111/j.1532-5415.1994.tb01746.x. PMID:8120307
- Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011;204:1879-85. https://doi.org/10.1093/infdis/jir661. PMID:21998477
- Trombetta CM, Montomoli E. Influenza immunology evaluation and correlates of protection: A focus on vaccines. Expert Rev Vaccines. 2016;15:967-76. https://doi.org/10.1586/14760584.2016.1164046. PMID:26954563
- Pepin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults. Vaccine. 2013;31:5572-8. https://doi.org/10.1016/j.vaccine.2013.08.069. PMID:24016810
- International Conference on Harmonisation. Guideline for clinical safety data management: Definitions and standards for expedited reporting; 1994 [accessed 2017 Feb 15]. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf.